This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: James Sheppeck: Inventor in Cancer Research
Introduction
James Sheppeck is an inventor based in Gaithersburg, Maryland, United States. His patent work concerns compounds designed to inhibit hematopoietic progenitor kinase 1 (HPK1), a target relevant to cancer treatment.
Latest Patents
Sheppeck is associated with 1 patent: “Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer.” The patent describes substituted pyrazine-2-carboxamides of Formula (I), their pharmaceutically acceptable salts, and compositions containing them. It also describes their use in therapy, particularly for the treatment or prevention of cancer.
Career Highlights
Sheppeck’s listed patent is associated with AstraZeneca AB. It focuses on HPK1-inhibiting compounds and their potential therapeutic applications.
Collaborations
The patent’s listed collaborators include Sten Nilsson-Lill and Kathryn Giblin.
Conclusion
James Sheppeck’s patent work, associated with AstraZeneca AB, centers on HPK1 inhibitors and their potential use in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile